AI
Saturday, March 27, 2010 11:39:44 AM
CBIS - Cannabis Science
Pharmaceutical company commercializing a variety of cannabinoid based pharmaceutical products.
Company highlights:
* Dr. Robert Melamede, President & CEO Cannabis Science Inc., stated, “We have made great progress and this is just the beginning. We are in the final stages before Cannabis Science files with the FDA for clinical trials.
* Reuters and ABCNews report that the UK and Spain are expected to approve GW Pharmaceuticals' whole-cannabis extract. Big Pharma "gets it", and is leading the way for Cannabis Science to develop several non-smoked cannabis pharmaceutical products it will bring to the FDA for clinical trials.
Technicals:
Currently in a decending triangle, the closer it gets to the apex, the more likely it is to breakout.
The 52 week high is 1.44 - the low is .05.
I currently own Cannabis. (just wanted to say that)
Pharmaceutical company commercializing a variety of cannabinoid based pharmaceutical products.
Company highlights:
* Dr. Robert Melamede, President & CEO Cannabis Science Inc., stated, “We have made great progress and this is just the beginning. We are in the final stages before Cannabis Science files with the FDA for clinical trials.
* Reuters and ABCNews report that the UK and Spain are expected to approve GW Pharmaceuticals' whole-cannabis extract. Big Pharma "gets it", and is leading the way for Cannabis Science to develop several non-smoked cannabis pharmaceutical products it will bring to the FDA for clinical trials.
Technicals:
Currently in a decending triangle, the closer it gets to the apex, the more likely it is to breakout.
The 52 week high is 1.44 - the low is .05.
I currently own Cannabis. (just wanted to say that)
All my my posts are my opinion, entertainment value only...
if you have done your own due diligence then trade with confidence, if not...
PRAY!
[img][chart]investorshub.advfn.com/uimage/uploads/2010/3/7/dinuep
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
